Latest News Archive

Please select Category, Year, and then Month to display items

Fighting COVID-19: Here is how we are helping

16 April 2020 | Story Department of Communication and Marketing | Photo Charl Devenish

Farmovs — In 2019, FARMOVS was pre-qualified by the WHO to support clinical studies aimed at improving access to quality generic medicines across the globe.

The University of the Free State (UFS) is committed to supporting government’s efforts to overcome the COVID-19 pandemic. During this challenging time, dedicated staff members at the UFS continue to provide services as a testimony to their commitment to advance public knowledge of COVID-19 for the greater good of South Africa.

The following is a synopsis of the areas in which the UFS is actively assisting.

Public Health Emergency Solidarity Trial
Clinicians from the Department of Internal Medicine, the Department of Critical Care, and the Division of Virology will be working with FARMOVS to participate in the Public Health Emergency Solidarity Trial initiated by the World Health Organization (WHO). This international randomised trial will evaluate four treatment options (remdesivir, lopinavir/ritonavir, lopinavir/ritonavir plus interferon, chloroquine or hydroxychloroquine) for the treatment of COVID-19.

The trial is expected to include more than 45 countries worldwide, including a number of South African sites.

Farmovs
FARMOVS is in a planning process to support all the Bloemfontein hospitals, including Pelonomi, Universitas, 3 Military Hospital, Mediclinic, and Rosepark, in conducting the largest global trial on COVID-19 – the Public Health Emergency Solidarity Trial, under leadership of the WHO.

Negotiations are ongoing between the UFS and the Department of Health in the Free State for FARMOVS to offer support with the continuation of healthcare to non-COVID-19 patients in an attempt to free up space at Universitas Hospital for isolation of COVID-19 patients.

In 2019, FARMOVS was pre-qualified by the WHO to support clinical studies aimed at improving access to quality generic medicines across the globe. FARMOVS also receives feasibility requests for support with the evaluation of existing drugs (repurposing) as well as the development of novel drugs for the treatment of COVID-19 – this is an ongoing process.

Disaster Management Training and Education Centre (DiMTEC)
DiMTEC represents the UFS on the Provincial Joint Operation Centre (PROVJOC). The PROVJOC is a fully equipped, dedicated facility that is proactively established to enable all relevant role players /disciplines to jointly manage all safety and security-related aspects of any planned event or any major incident which has occurred or is imminent – especially in the response and recovery operations phase – at the strategic and/or tactical level, using the Unified Command System. This facility is also linked to all other established safety and security centres.

Research and Innovation
The UFS hosts a SARChI Research Chair in vector-borne and zoonotic diseases, and recently invested in the establishment of a biosafety level-3 facility. Hence, there is expertise on the campus to plan and conduct research on zoonotic and medically significant viruses. In addition, there are research groups focusing on protein expression systems with potential for utilisation in the development of diagnostic assays with application in either diagnosis or surveillance.

Currently, researchers at the UFS have established several projects that will contribute directly towards the COVID-19 outbreak.

News Archive

New York academic pays visit to UFS

2010-08-02

Prof. Teboho Moja, a professor of Higher Education at NYU, paid a successful visit to the UFS. Here are, from left: Mr John Samuel, Interim Director: International Institute for Studies in Race, Reconciliation and Social Justice, UFS; Dr Bryan Urbsaitis, Assistant-Director of Study Abroad, Pace University, USA; Prof. Moja; Prof. Jonathan Jansen, Rector and Vice-Chancellor, UFS; and Dr Olihile Sebolai, Directorate Research Development, UFS.
Photo: Arthur Johnson

Prof. Teboho Moja, a professor of Higher Education from New York University (NYU), paid a fruitful visit to the University of the Free State (UFS). During her visit Prof. Moja, who is originally from South Africa, engaged with various stakeholders to further strengthen relations between the UFS and NYU.

Prof. Moja’s research focus is on the change in higher education and the implications of globalisation on higher education systems. As part of her visit to the UFS, Prof. Moja delivered a public lecture, entitled “Diversity oriented transformation for Teaching and Learning”. The lecture was presented by the Directorate Research Development and the International Institute for Studies in Race, Reconciliation and Social Justice.

Prof. Moja studied at the University of the Witwatersrand and obtained her Doctorate in Philosophy at the University of Wisconsin-Madison in the United States of America (USA).

In 1998 she became the first black woman to be appointed as chairperson of the council of the University of South Africa (UNISA). She is also an honorary professor at the University of Pretoria (UP).

On her visit to the UFS Prof. Moja was accompanied by Dr Bryan Urbsaitis from Pace University in New York and Ms Gina Canterucci from NYU. She also led a group of postgraduate students in International Education Studies. These students interacted with fellows from the Grow Our Own Timber Programme of the UFS. The interaction greatly contributed towards enhancing both student groups’ acuity on academic and social matters.

Back

Economic and Management Sciences

Education

Health Sciences

The Humanities

Law

Natural and Agricultural Sciences

Theology and Religion

Open Distance Learning

Business School

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept